Kaya Holdings, Inc. (OTCQB:KAYS) Urgent update; Viewing Platform Change for Today’s Annual Online Shareholder Meeting

FT. LAUDERDALE, Fla., Dec. 20, 2017 -- Kaya Holdings, Inc. (OTCQB:KAYS), confirmed today that the KAYS webinar will start in less than an hour (today, Wednesday, December 20th, 2017,1:00 PM EST) but the viewing platform has changed from Gotowebinar to Zoom Meetings.

Webinar will not be viewable unless you use the updated viewing info. You do not need to reregister, and to view simply access the following link:

https://zoom.us/j/614926250

This system works for windows, apple, smartphones or just about any computer system that you may have. Just follow the few short prompts and enter your name and email address and watch the meeting unfold.

The presentation is expected to last between 60-90 minutes and feature 3 videos and an online live discussion with Craig Frank, KAYS Chairman, CEO and Acting CFO, and W. David Jones, Senior Advisor for Business Development and Licensing.

Items to be viewed and topics to be discussed include never-seen-before video of Kaya Shack operations, architectural plans of the planned Kaya Farms™ 100K Square Foot Grow and Manufacturing Facilities on recently acquired 26 acre farmland, Kaya Shack™ store performance, new store development, OLCC licensing update, new brands to be introduced in 2018 and an industry overview.

 About Kaya Holdings, Inc.
(www.kayaholdings.com)
KAYS (OTCQB:KAYS), through subsidiaries, produces, distributes and sells legal premium medical and recreational cannabis products, including flower, concentrates and oils, and cannabis-infused foods.

In 2014, KAYS, became the first publicly traded company to own and operate a Medical Marijuana Dispensary. KAYS presently operates three Kaya Shack™ OLCC licensed marijuana retail stores to service the legal medical and recreational marijuana market in Oregon, with store number four currently under construction. Additionally, KAYS recently acquired a 26 acre parcel which it has targeted for development of the Kaya Farms™ Medical and Recreational Marijuana Grow and Manufacturing Complex.

IMPORTANT DISCLOSURE: KAYS is planning execution of its stated business objectives in accordance with current understanding of State and Local Laws and Federal Enforcement Policies and Priorities as it relates to Marijuana (as outlined in the Justice Department's Cole Memo dated August 29, 2013), and plan to proceed cautiously with respect to legal and compliance issues. Potential investors and shareholders are cautioned that AFAI and MJAI will obtain advice of counsel prior to actualizing any portion of their business plan (including but not limited to license applications for the cultivation, distribution or sale of marijuana products, engaging in said activities or acquiring existing Cannabis production/sales operations). Advice of counsel with regard to specific activities of KAYS and MJAI, Federal, State or Local legal action or changes in Federal Government Policy and/or State and Local Laws may adversely affect business operations and shareholder value.

Forward Looking Statements

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

For more information contact Investor Relations: 954-892-6911.